Coave Therapeutics

2 followers


Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.

Industries

Headquarters

Paris, France

Employees

11-50

Links


Org chart

Rodolphe Clerval
CEO & Director
Collapse
Claudia Mitchell
Interim Chief Scientific Officer
Julien Berger
VP, Legal Affairs & Corporate Secretary
Cédric Cousteix
Finance Director
Lolita Petit
Chief Scientific Officer
Willem Broekaert
Board Director/observer

Board & advisors

Andrea Ballabio
Scientific Advisor
Erwan Bézard
Scientific Advisor
Aravind Asokan
Scientific Advisor
Mark Kay
Scientific Advisor
Robert Kotin
Scientific Advisor
Alain Wagner
Scientific Advisor
Juliette Hordeaux
Scientific Advisor
Anne Des Rieux
Scientific Advisor